
    
      Following a screening visit, eligible subjects will be enrolled into the study. Each subject
      will receive 3 treatments 4 weeks apart and 3 Follow Up visits, at 1, 3, and 6 months
      following the last treatment.

      Further demographic information and patient history will be obtained from the subjects'
      electronical files.
    
  